Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05591001Phase 1Completed
Phase 1, randomised, double-blind trial of ketamine and dexmedetomidine in Tethered cord syndrome (TCS) (2 arms), sponsored by Cairo University. Primary endpoint: Mean microvolts of Motor Evoked Potentials at 2 hours. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05591001.